| 靶点: |
Ki: 1.8 nM (MOP), 4.2 nM (NOP) |
| 体内研究: |
BPR1M97 (1.8 mg/kg; s.c.; once) demonstrates antinociception in a murine model of cancer pain. |
| 参考文献: |
1. Chao PK, et al. BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, producespotent antinociceptive effects with safer properties than morphine. Neuropharmacology. 2019 Jul 3:107678. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.863 ml |
14.316 ml |
28.633 ml |
| 5 mM |
0.573 ml |
2.863 ml |
5.727 ml |
| 10 mM |
0.286 ml |
1.432 ml |
2.863 ml |
| 50 mM |
0.057 ml |
0.286 ml |
0.573 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |